Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference

Henry Chrystyn; Hicham Benhaddi; Marianka  van der Tol; Jaco Voorham; John Haughney; Sinthia Bosnic-Anticevich; David Price; N. Roche

doi:10.1183/1393003.congress-2017.PA3889

Abstract

Background: Most patients use their inhaler devices incorrectly (Price et al Eur Respir J 2014), but many medical centres lack sufficient resources to train patients (pts).

Aims/Objectives: To compare the time needed to achieve device mastery between Spiromax and other commonly prescribed inhalers, and to assess inhaler preferences.

Methods: A cross-sectional observational study in asthma and COPD review clinics in the UK assessing pts using their current inhalers (DuoResp Spiromax, Symbicort Turbohaler, Advair Diskus [DPIs] or Ventolin Evohaler [pMDI]) [session 1], and 2 sequentially allocated alternative devices [session 2 and 3]. The duration of training sessions required to reach error-free device mastery was captured. All pts completed a customized Asthma/COPD device preference questionnaire (adapted from a validated questionnaire).

Results: On average, pts (asthma n=93; COPD n=79) achieved device mastery faster with Spiromax compared to the other DPI devices (Table 1) [p
Conclusions: Asthma and COPD pts achieved device mastery faster with Spiromax vs other devices. Also, asthma and COPD pts preferred Spiromax vs the other DPI devices. Asthma patients preferred the pMDI.

Original language	English
Article number	PA3889
Number of pages	1
Journal	European Respiratory Journal
Volume	50
Issue number	Supplement 61
DOIs	https://doi.org/10.1183/1393003.congress-2017.PA3889
Publication status	Published - 2017
Externally published	Yes
Event	European Respiratory Society (ERS) International Congress 2017 - Milan, Italy Duration: 9 Sept 2017 → 13 Sept 2017

Access to Document

10.1183/1393003.congress-2017.PA3889

Cite this

Chrystyn, H., Benhaddi, H., van der Tol, M., Voorham, J., Haughney, J., Bosnic-Anticevich, S., Price, D., & Roche, N. (2017). Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference. European Respiratory Journal, 50(Supplement 61), Article PA3889. https://doi.org/10.1183/1393003.congress-2017.PA3889

@article{caf3e99a48654e56bf3e83e397a301a4,

title = "Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference",

abstract = "Background: Most patients use their inhaler devices incorrectly (Price et al Eur Respir J 2014), but many medical centres lack sufficient resources to train patients (pts).Aims/Objectives: To compare the time needed to achieve device mastery between Spiromax and other commonly prescribed inhalers, and to assess inhaler preferences.Methods: A cross-sectional observational study in asthma and COPD review clinics in the UK assessing pts using their current inhalers (DuoResp Spiromax, Symbicort Turbohaler, Advair Diskus [DPIs] or Ventolin Evohaler [pMDI]) [session 1], and 2 sequentially allocated alternative devices [session 2 and 3]. The duration of training sessions required to reach error-free device mastery was captured. All pts completed a customized Asthma/COPD device preference questionnaire (adapted from a validated questionnaire).Results: On average, pts (asthma n=93; COPD n=79) achieved device mastery faster with Spiromax compared to the other DPI devices (Table 1) [pConclusions: Asthma and COPD pts achieved device mastery faster with Spiromax vs other devices. Also, asthma and COPD pts preferred Spiromax vs the other DPI devices. Asthma patients preferred the pMDI.",

author = "Henry Chrystyn and Hicham Benhaddi and {van der Tol}, Marianka and Jaco Voorham and John Haughney and Sinthia Bosnic-Anticevich and David Price and N. Roche",

year = "2017",

doi = "10.1183/1393003.congress-2017.PA3889",

language = "English",

volume = "50",

journal = "European Respiratory Journal",

issn = "1399-3003",

publisher = "European Respiratory Society",

number = "Supplement 61",

note = "European Respiratory Society (ERS) International Congress 2017 ; Conference date: 09-09-2017 Through 13-09-2017",

}

Chrystyn, H, Benhaddi, H, van der Tol, M, Voorham, J, Haughney, J, Bosnic-Anticevich, S, Price, D & Roche, N 2017, 'Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference', European Respiratory Journal, vol. 50, no. Supplement 61, PA3889. https://doi.org/10.1183/1393003.congress-2017.PA3889

TY - JOUR

T1 - Comparing asthma and COPD inhaler devices in real life clinical practice in the UK

T2 - European Respiratory Society (ERS) International Congress 2017

AU - Chrystyn, Henry

AU - Benhaddi, Hicham

AU - van der Tol, Marianka

AU - Voorham, Jaco

AU - Haughney, John

AU - Bosnic-Anticevich, Sinthia

AU - Price, David

AU - Roche, N.

PY - 2017

Y1 - 2017

N2 - Background: Most patients use their inhaler devices incorrectly (Price et al Eur Respir J 2014), but many medical centres lack sufficient resources to train patients (pts).Aims/Objectives: To compare the time needed to achieve device mastery between Spiromax and other commonly prescribed inhalers, and to assess inhaler preferences.Methods: A cross-sectional observational study in asthma and COPD review clinics in the UK assessing pts using their current inhalers (DuoResp Spiromax, Symbicort Turbohaler, Advair Diskus [DPIs] or Ventolin Evohaler [pMDI]) [session 1], and 2 sequentially allocated alternative devices [session 2 and 3]. The duration of training sessions required to reach error-free device mastery was captured. All pts completed a customized Asthma/COPD device preference questionnaire (adapted from a validated questionnaire).Results: On average, pts (asthma n=93; COPD n=79) achieved device mastery faster with Spiromax compared to the other DPI devices (Table 1) [pConclusions: Asthma and COPD pts achieved device mastery faster with Spiromax vs other devices. Also, asthma and COPD pts preferred Spiromax vs the other DPI devices. Asthma patients preferred the pMDI.

AB - Background: Most patients use their inhaler devices incorrectly (Price et al Eur Respir J 2014), but many medical centres lack sufficient resources to train patients (pts).Aims/Objectives: To compare the time needed to achieve device mastery between Spiromax and other commonly prescribed inhalers, and to assess inhaler preferences.Methods: A cross-sectional observational study in asthma and COPD review clinics in the UK assessing pts using their current inhalers (DuoResp Spiromax, Symbicort Turbohaler, Advair Diskus [DPIs] or Ventolin Evohaler [pMDI]) [session 1], and 2 sequentially allocated alternative devices [session 2 and 3]. The duration of training sessions required to reach error-free device mastery was captured. All pts completed a customized Asthma/COPD device preference questionnaire (adapted from a validated questionnaire).Results: On average, pts (asthma n=93; COPD n=79) achieved device mastery faster with Spiromax compared to the other DPI devices (Table 1) [pConclusions: Asthma and COPD pts achieved device mastery faster with Spiromax vs other devices. Also, asthma and COPD pts preferred Spiromax vs the other DPI devices. Asthma patients preferred the pMDI.

U2 - 10.1183/1393003.congress-2017.PA3889

DO - 10.1183/1393003.congress-2017.PA3889

M3 - Meeting abstract

SN - 1399-3003

VL - 50

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - Supplement 61

M1 - PA3889

Y2 - 9 September 2017 through 13 September 2017

ER -

Comparing asthma and COPD inhaler devices in real life clinical practice in the UK: differences in training requirements and preference

Abstract

Access to Document

Fingerprint

Cite this